Acumen Pharmaceuticals (ABOS) PEG Ratio

Price: $1.02
Market Cap: $61.78M
Avg Volume: 235.07K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.098
52W Range: $0.855-3.92
Website: Acumen Pharmaceuticals

PEG Ratio Summary

  • Acumen Pharmaceuticals's trailing twelve month (TTM) PEG ratio is 0.02.
  • Acumen Pharmaceuticals's annual PEG ratio as of today is -0.02.
  • Acumen Pharmaceuticals's quarterly PEG ratio is -0.03.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess Acumen Pharmaceuticals's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -1.01
    • Quarterly: -0.69
    • TTM: -0.60
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 0.57
    • Quarterly: 0.57
    • TTM: 0.34
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -1.20
    • Quarterly: -3.79
    • TTM: -0.71

These metrics provide insights into Acumen Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

0.02

Annual PEG Ratio

-0.02

Quarterly PEG Ratio

-0.03

Acumen Pharmaceuticals Historical PEG Ratio

12.0012.009.009.006.006.003.003.000.000.00-3.00-3.00PEG Ratio-0.02-0.440.07-0.0011.020.00202020202021202120222022202320232024202420252025

Historical P/E Ratio

0.000.00-30.00-30.00-60.00-60.00-90.00-90.00-120.00-120.00P/E Ratio-1.01-3.56-5.42-1.51-110.19-102.65202020202021202120222022202320232024202420252025

Historical P/S Ratio

600.00600.00500.00500.00400.00400.00300.00300.00200.00200.00100.00100.000.000.00P/S Ratio0.000.000.000.00562.01475.58202020202021202120222022202320232024202420252025

Historical P/B Ratio

20.0020.000.000.00-20.00-20.00-40.00-40.00-60.00-60.00-80.00-80.00P/B Ratio0.570.701.161.22-43.41-70.67202020202021202120222022202320232024202420252025

Historical P/CF Ratio

0.000.00-30.00-30.00-60.00-60.00-90.00-90.00-120.00-120.00P/CF Ratio-1.20-4.32-6.24-15.23-108.33-118.37202020202021202120222022202320232024202420252025

Acumen Pharmaceuticals Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2024 -0.02 -1.01 0.00 0.57 -1.20
2023 -0.44 -3.56 0.00 0.70 -4.32
2022 0.07 -5.42 0.00 1.16 -6.24
2021 0.00 -1.51 0.00 1.22 -15.23
2020 11.02 -110.19 562.01 -43.41 -108.33
2019 0.00 -102.65 475.58 -70.67 -118.37

Related Metrics

Explore detailed financial metrics and analysis for ABOS.